Company intelligence / Profile preview

Modilac

Ownership: Private
Development stage: Commercial

Overview

Modilac is a company specializing in infant nutrition products. It offers a range of formulas and foods designed to support babies during weaning and early childhood development. There is no evidence that Modilac develops pharmaceuticals or biotechnological therapies.

Therapeutic areas: Metabolic DisordersGastroenterology
Industry: Food & Nutrition

Drug pipeline

3 assets

Bio Lf+2

Commercial

Indications: Infant nutrition

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Modilac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modilac.

Explore the full profile